This inventor holds 1 USPTO granted patent. Top assignee: Societe Cortial, S.a.. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Christian Courtiol: Innovator in Pharmaceutical Chemistry
Introduction
Christian Courtiol is a notable inventor based in Pessac, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. His work is characterized by a focus on innovative chemical derivatives that exhibit specific biological activities.
Latest Patents
One of Courtiol's key patents is titled "Derivatives of 4-aminoethoxy-5-isopropyl-2-methylbenzenes: methods of - A compound with alpha 1-blocking activity." This patent describes a compound with the formula: ##STR1## wherein R.sub.1 is --H, --CH.sub.3 or --COCH.sub.3; R.sub.2 is --H or CH.sub.3; and R.sub.3 is ##STR2## wherein .SIGMA. is --H or one or more substituents selected from the group consisting of halogen, --OH and --OCH.sub.3; or a pharmaceutically acceptable salt thereof. This innovation highlights his expertise in creating compounds that can potentially lead to new therapeutic options.
Career Highlights
Courtiol is associated with Societe Cortial, S.A., where he continues to advance his research and development efforts. His career is marked by a commitment to innovation in the pharmaceutical sector, contributing to the advancement of medical science through his inventions.
Collaborations
Throughout his career, Courtiol has collaborated with esteemed colleagues, including Henri Pontagnier and Marie-Hélène Creuzet. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Christian Courtiol stands out as an inventor dedicated to advancing pharmaceutical chemistry through innovative compounds. His contributions, particularly in the area of alpha 1-blocking agents, reflect his commitment to improving therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile